Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|August 18, 2023
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, CanadaAneeka Hafeez, Lauren E Cipriano, Richard B Kim, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2022
Stone Prevalence in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-AnalysisVinusha Kalatharan, Gary Grewal, Danielle M Nash, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 17, 2023
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysisMichael Situ, Ute I Schwarz, Guangyong Zou, et al.
Canadian Journal of Kidney Health and Disease|December 7, 2020
Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort StudyVinusha Kalatharan, Blayne Welk, Danielle M Nash, et al.
Canadian Journal of Kidney Health and Disease|August 6, 2020
Efficacy and Safety of Surgical Kidney Stone Interventions in Autosomal Dominant Polycystic Kidney Disease: A Systematic ReviewVinusha Kalatharan, Racquel Jandoc, Gary Grewal, et al.
Canadian Journal of Kidney Health and Disease|April 2, 2021
Risk of Hospital Encounters With Kidney Stones in Autosomal Dominant Polycystic Kidney Disease: A Cohort StudyVinusha Kalatharan, Blayne Welk, Danielle M Nash, et al.
Health Economics|September 17, 2019
Production of physician services under fee-for-service and blended fee-for-service: Evidence from Ontario, CanadaNibene H Somé, Rose Anne Devlin, Nirav Mehta, et al.
Transplantation|July 26, 2018
Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney DonorsSteven Habbous, Sisira Sarma, Lianne J Barnieh, et al.
Pharmacoeconomics - Open|April 7, 2018
The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort StudyMalek B Hannouf, Eric Winquist, Salaheddin M Mahmud, et al.
Cancer Research and Treatment|March 22, 2017
The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort StudyMalek B Hannouf, Eric Winquist, Salaheddin M Mahmud, et al.
Pageof 9